Robuta

https://www.semanticscholar.org/topic/Anti-FGFR2-Antibody-BAY1179470/12296444 Anti-FGFR2 Antibody BAY1179470 | Semantic Scholar An antibody against the fibroblast growth factor receptor type 2 (FGFR2), with potential antineoplastic activity. Upon administration, the anti-FGFR2 antibody... antifgfr2scholar https://www.news-medical.net/news/20231228/Insilico-Medicine-develops-new-AI-generated-FGFR23-inhibitor-for-tissue-agnostic-solid-tumors.aspx Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors Dec 28, 2023 - Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of... https://www.jci.org/articles/view/68899 JCI - FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma squamous celljcifgfr2signalingp63 https://elifesciences.org/articles/104060 Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric... Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but... https://www.jci.org/assets/293891/powerpoint JCI - FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma squamous celljcifgfr2signalingp63 https://www.massgeneral.org/cancer-center/clinician-resources/advances/secondary-fgfr2-mutations-drive-drug-resistance-to-fgfr-inhibitors-in-bile-duct-cancer Secondary FGFR2 Mutations Drive Drug Resistance in Bile Duct Cancer Can understanding the genetic mechanisms driving resistance to the FGFR inhibitor BGJ398 lead to better therapies for bile duct and other cancers? The Mass... drug resistancebile ductsecondaryfgfr2mutations https://www.thermofisher.com/antibody/product/FGFR2-Antibody-Polyclonal/PA1-31990 FGFR2 Polyclonal Antibody | Invitrogen (PA1-31990) Detect FGFR2 in WB, ELISA, IHC (P), ICC/IF, Flow. Reacts with Mouse, Rabbit, Goat, Human. Catalog # PA1-31990 polyclonal antibodyfgfr2invitrogenpa131990 https://pmc.ncbi.nlm.nih.gov/articles/PMC6672025/ Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma... Cholangiocarcinoma is a highly aggressive and lethal malignancy, with limited treatment options available. Recently, FGFR inhibitors have been developed and... tumor heterogeneitydrug resistanceacquired https://www.rcsb.org/structure/8W3B RCSB PDB - 8W3B: TAS-120 covalent structure with FGFR2 molecular brake mutant TAS-120 covalent structure with FGFR2 molecular brake mutant rcsb pdb https://www.rcsb.org/structure/4WV1 RCSB PDB - 4WV1: Crystal structure of the FGFR2 D2 domain in complex with Fab 2B.1.3 Crystal structure of the FGFR2 D2 domain in complex with Fab 2B.1.3 https://www.muni.cz/en/research/publications/982600 p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. | Masaryk... https://www.rcsb.org/structure/8U1F RCSB PDB - 8U1F: FGFR2 Kinase Domain Bound to Irreversible Inhibitor Cmpd 10 FGFR2 Kinase Domain Bound to Irreversible Inhibitor Cmpd 10 rcsb pdb